194 related articles for article (PubMed ID: 1331628)
1. Biochemical evaluation of adrenal dysfunction: the laboratory perspective.
Snow K; Jiang NS; Kao PC; Scheithauer BW
Mayo Clin Proc; 1992 Nov; 67(11):1055-65. PubMed ID: 1331628
[TBL] [Abstract][Full Text] [Related]
2. [Cushing's syndrome: a diagnostic strategy].
Bouallouche A; Vermeulen C; Brerault JL; Fiet J; Julien R; Guillevin L
Sem Hop; 1984 Apr; 60(15):1083-8. PubMed ID: 6326300
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
4. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
Johannesen O; Jørgensen H; Frey H; Norman N
Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
[TBL] [Abstract][Full Text] [Related]
7. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
9. Cushing's syndrome: a review of diagnostic tests.
Crapo L
Metabolism; 1979 Sep; 28(9):955-77. PubMed ID: 225638
[TBL] [Abstract][Full Text] [Related]
10. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
11. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
Reznik Y; Allali-Zerah V; Chayvialle JA; Leroyer R; Leymarie P; Travert G; Lebrethon MC; Budi I; Balliere AM; Mahoudeau J
N Engl J Med; 1992 Oct; 327(14):981-6. PubMed ID: 1325609
[TBL] [Abstract][Full Text] [Related]
12. Appropriate laboratory testing in the screening and work-up of Cushing's syndrome.
Fuhrman SA
Am J Clin Pathol; 1988 Sep; 90(3):345-50. PubMed ID: 2843035
[TBL] [Abstract][Full Text] [Related]
13. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
14. [Cushing's syndrome: diagnostic exploration].
Tabarin A; Roger P
Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
[TBL] [Abstract][Full Text] [Related]
15. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
17. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of hypothalamic-pituitary-adrenocortical function tests in patients with Cushing's syndrome.
Hashimoto K
Acta Med Okayama; 1975 Apr; 29(2):111-26. PubMed ID: 169671
[TBL] [Abstract][Full Text] [Related]
19. Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome.
Bruno OD; Rossi MA; Contreras LN; Gómez RM; Galparsoro G; Cazado E; Kral M; Leber B; Arias D
Acta Endocrinol (Copenh); 1985 Jun; 109(2):158-62. PubMed ID: 2990131
[TBL] [Abstract][Full Text] [Related]
20. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]